Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Panel divides over wider fentanyl penalties; Senate Judiciary rejects expanded felony measure

2257840 · February 10, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senate Bill 44, a proposal to raise penalties on fentanyl possession and distribution, prompted divided testimony Monday as family members, law‑enforcement officials and public‑health experts debated whether tougher criminal penalties would reduce overdoses; the committee voted 3‑4 to reject the bill.

Senate Bill 44, a proposal to increase penalties for fentanyl possession, distribution and manufacture, produced sharply divided testimony and emotional appeals from families who have lost children to counterfeit pills. After an extended hearing that included law enforcement, public‑health experts, addiction specialists and numerous family members, the Senate Judiciary Committee voted 3‑4 to reject the measure in committee.

Sponsor Sen. Tim Peltonbee framed the bill as a tool to target drug dealers and cartel activity, reduce street availability of fentanyl and give prosecutors a stronger statutory basis to pursue large‑scale distributors. “This bill takes fentanyl and moves the drug to a class‑1 drug felony if anybody is manufacturing, dispensing, selling or possessing with intent to do the same,” Peltonbee told the committee, and described multiple local law‑enforcement requests to strengthen penalties.

Many law‑enforcement witnesses —…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans